[1]BioorganicandMedicinalChemistry,2006,vol.14,p.7816-7825
[1]OrganicLetters,2007,vol.9,p.2131-2134
[2]Patent:WO2019/243273,2019,A1.Locationinpatent:Page/Pagecolumn98-99
[3]ChemicalCommunications,2007,p.3136-3138
[4]Patent:CN110964043,2020,A.Locationinpatent:Paragraph0052;0068-0069
[5]JournalofMedicinalChemistry,2009,vol.52,p.7003-7013
[6]JournalofMedicinalChemistry,2009,vol.52,p.6494-6498
[7]JournalofMedicinalChemistry,2022,vol.65,p.460-484
[8]JournalofNaturalProducts,2010,vol.73,p.1659-1666
[9]BioorganicandMedicinalChemistry,2006,vol.14,p.7816-7825
[10]Biomacromolecules,2012,vol.13,p.350-357
[11]Tetrahedron,2018,vol.74,p.5102-5112
[1]OrganicLetters,2007,vol.9,p.2131-2134
[2]Patent:US2016/361436,2016,A1
[3]Patent:WO2019/243273,2019,A1
[4]JournalofMedicinalChemistry,2022,vol.65,p.460-484
[1]BioorganicandMedicinalChemistry,2006,vol.14,p.7816-7825
[1]OrganicandBiomolecularChemistry,2008,vol.6,p.523-531
Title: Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-1014.